A comprehensive view of Epidemic/Pandemic. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Commentary: Analysts upgrade China's 2023 earnings forecasts on reopening hopes; UBS expects significant easing in Covid restrictions in Q2 2023 and earnings growth of 15%-20% for MSCI China index, underpinned by lower commodity prices and economic growth

Study finds Moderna COVID vaccine safe, comparably effective in preschoolers: Emory University and Moderna

Amazon CEO says its mass layoffs are due to economic uncertainty ahead that prompted company to cut back on expenses; company knew it 'might be overbuilding' when it added as many as many as 1,400 new hires/day during early pandemic growth

Catalent lays off over 210 employees in Texas and Maryland, 400 people in Bloomington, Indiana, due to crash in revenue from COVID-19-related products

Canada to buy 15,000 treatment courses of Roche’s Actemra IV tocilizumab injectable to treat adult patients hospitalized with COVID-19; an estimated 429 out of 1,000 patients hospitalized with COVID-19 are eligible for tocilizumab

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count